Evidence item

The primary Nature Medicine report directly gives the three-round specificity and all-cancer episode-sensitivity ranges in the claim. DIRECT_TEXT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 16851

Source: Performance of a multi-cancer early detection test in the randomized controlled NHS-Galleri trial · locator {} · excerpt hash sha256:3b43e3b9cc91bb220d6baa2129d24f388cd43541ef06d04edaaf058fc5750a3a

Across rounds, specificity ranged from 99.50% to 99.60%; episode sensitivity ranged from 26.7% to 37.2% for all cancers and from 47.6% to 63.4% for 12 prespecified types; and CSO accuracy ranged from 91.1% to 93.6%.